These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8338878)

  • 21. Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus.
    Fischinger PJ; Frankel AE; Elder JH; Lerner RA; Ihle JN; Bolognesi DP
    Virology; 1978 Oct; 90(2):241-54. PubMed ID: 214945
    [No Abstract]   [Full Text] [Related]  

  • 22. Introduction of a selectable gene into different animal tissue by a retrovirus recombinant vector.
    Stuhlmann H; Cone R; Mulligan RC; Jaenisch R
    Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7151-5. PubMed ID: 6095271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
    Holzer GW; Mayrhofer JA; Gritschenberger W; Dorner F; Falkner FG
    Virology; 1999 Jan; 253(1):107-14. PubMed ID: 9887323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Moloney murine leukaemia virus by a retroviral vector, LNL6, carrying ribozymes targeted to the 5' non-coding sequence.
    Lowenstein P; Symonds G
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2587-90. PubMed ID: 9349479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo.
    Kubo S; Haga K; Tamamoto A; Palmer DJ; Ng P; Okamura H; Kasahara N
    Mol Ther; 2011 Jan; 19(1):76-82. PubMed ID: 20808291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors.
    Chen J; Reeves L; Cornetta K
    Hum Gene Ther; 2001 Jan; 12(1):61-70. PubMed ID: 11177543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target and non-target effects of retrovirus vectors used for gene therapy and vaccination.
    Onions D
    Dev Biol Stand; 1995; 84():59-74. PubMed ID: 7796969
    [No Abstract]   [Full Text] [Related]  

  • 28. A recombinant murine retrovirus expressing v-rel is cytopathic.
    Schwartz RC; Witte ON
    Virology; 1988 Jul; 165(1):182-90. PubMed ID: 2838956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An improved method for detection of replication-competent retrovirus in retrovirus vector products.
    Uchida E; Sato K; Iwata A; Ishii-Watabe A; Mizuguchi H; Hikata M; Murata M; Yamaguchi T; Hayakawa T
    Biologicals; 2004 Sep; 32(3):139-46. PubMed ID: 15536044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of being RCR.
    Günzburg WH
    Curr Opin Mol Ther; 2001 Oct; 3(5):437-8. PubMed ID: 11699887
    [No Abstract]   [Full Text] [Related]  

  • 31. Frequency of missense mutations in the coding region of a eukaryotic gene transferred by retroviral vectors.
    De Angioletti M; Rovira A; Sadelain M; Luzzatto L; Notaro R
    J Virol; 2002 Feb; 76(4):1991-4. PubMed ID: 11799194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.
    Paar M; Schwab S; Rosenfellner D; Salmons B; Günzburg WH; Renner M; Portsmouth D
    J Virol; 2007 Jul; 81(13):6973-83. PubMed ID: 17442710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different mechanisms account for the relative resistance of KG-1 and HL-60 cell lines to retrovirus infection.
    Collins SJ
    J Virol; 1988 Nov; 62(11):4346-8. PubMed ID: 3172344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors.
    Wilson CA; Ng TH; Miller AE
    Hum Gene Ther; 1997 May; 8(7):869-74. PubMed ID: 9143913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved detection of replication-competent retrovirus.
    Forestell SP; Dando JS; Böhnlein E; Rigg RJ
    J Virol Methods; 1996 Jul; 60(2):171-8. PubMed ID: 8844623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electron-microscopic demonstration of virus particles in acute lymphoblastic leukaemia in Sprague-Dawley rats.
    Schramlová J; Otová B; Cerný J; Blazek K
    Folia Biol (Praha); 1994; 40(3):113-8. PubMed ID: 7805932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Was it just stupid or are we poor educators?
    Anderson WF
    Hum Gene Ther; 1994 Jul; 5(7):791-2. PubMed ID: 7981304
    [No Abstract]   [Full Text] [Related]  

  • 38. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
    Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
    Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of antigenic epitopes as the result of env gene recombination in retrovirus-induced leukemia in immunocompetent mice.
    Tumas KM; Poszgay JM; Avidan N; Ksiazek SJ; Overmoyer B; Blank KJ; Prystowsky MB
    Virology; 1993 Feb; 192(2):587-95. PubMed ID: 7678475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus.
    Kinsella TM; Nolan GP
    Hum Gene Ther; 1996 Aug; 7(12):1405-13. PubMed ID: 8844199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.